Form

"*" indicates required fields

Bulk and Custom Quotation Request

If you need a product to meet a specific quality requirement, bulk quantity or packaging formats, Please use this form to request price and lead time.

"*" indicates required fields

Step 1 of 3

Trusted Weight:

Form

  • Hidden
  • Hidden
  • Hidden

Category: News

ILC Dover Announces Multi-compendial Water for Injection (WFI) for Growing Biotherapeutic and Cell & Gene Therapy Markets

By

NEWARK, Del. July 28, 2022 —ILC Dover LP (“ILC Dover” or the “Company”), specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced the launch of Water for Injection (WFI) for the biotherapeutics market. Used for the preparation of media, buffers, and other ingredients for biopharmaceuticals and medical devices, this launch continues to expand […]

ILC Dover Announces European Launch of Sentinel Clear XE™ PAPR

By

Sentinel Clear XE™ Hood and XE Blower deliver highest possible protection and performance for pharmaceutical and life sciences workers NEWARK, Del. [July 21, 2022] — ILC Dover Inc., specializing in innovative single-use solutions for global biotherapeutics and pharmaceutical processing as well as personal protective equipment (PPE), announced the European launch of the Sentinel Clear XE™ […]

ILC Dover Among Industry Team Selected to Provide the Next Generation of Spacesuits for NASA

By

NEWARK, Del. – June 3, 2022 – ILC Dover, the leading provider of spacesuits since the Apollo era, has been selected as part of the Collins Aerospace -led  team of industry leaders, along Oceaneering, to produce NASA’s next-generation extravehicular spacesuit. This next-generation extravehicular spacesuit could be worn by astronauts while working outside the International Space […]

ILC Dover Adds New European Manufacturing Location to Meet Growing Demand

By

New Gliwice, Poland Manufacturing Facility Expands Global Footprint in Life Sciences Market NEWARK, Del. – May 9, 2022 — ILC Dover LP (“ILC Dover” or the “Company”), specializing in innovative single-use and chemical workflow solutions for biotherapeutics and pharmaceutical processing, announced plans to break ground on a new 90,000 sq ft manufacturing site located in […]

ILC Dover Announces Liquid Single-Use Bioprocessing Bags for Rapidly Growing Biotherapeutics and Cell & Gene Therapy Markets

By

NEWARK, Del. – March 28, 2022 — ILC Dover LP (“ILC Dover” or the “Company”), specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced its launch of liquid single-use bioprocessing bags, representing the first of many new products for handling and supply of sterile liquids for the biotherapeutics market. This expansion is a […]

ILC Dover Announces North America Expansion to Meet Growing Demand

By

NEWARK, Del. – March 10, 2022 — ILC Dover LP (“ILC Dover” or the “Company”), specializing in innovative single-use and chemical workflow solutions for biotherapeutics and pharmaceutical processing, announced plans to significantly expand production capabilities in its Juarez, Mexico facility. This expansion is in response to the Company’s unprecedented growth in its life sciences business […]

ILC Dover Defines the Future of Sterile Manufacturing with the soloPURE™ Flexible Aseptic Isolator

By

NEWARK, Del., April 13, 2021  — ILC Dover LP (“ILC Dover” or the “Company”), specializing in the innovative design and production of single-use flexible solutions for global pharmaceutical and biopharmaceutical processing, today introduced the soloPURE™ flexible aseptic isolator, a cost-effective, closed-barrier system for sterile manufacturing. With a fully disposable, single-use chamber and a CAPEX-efficient compact […]

Driving Expansion, ILC Dover Appoints New President in Pharmaceutical / Biopharmaceutical Business Unit

By

Frederica, Delaware, December 9, 2020 –  ILC Dover, a world leader in the design and production of single-use flexible solutions for pharmaceutical and biopharmaceutical manufacturing, today named David Radspinner as President of the Pharmaceutical/Biopharmaceutical Business Unit, effective December 14, 2020. In his new role, Dr. Radspinner is expected to contribute to ILC Dover’s continued growth by building and […]